Vaccination with inhibin-α provides effective immunotherapy against testicular stromal cell tumors

BACKGROUND: Testicular cancer is the most common male neoplasm occurring in men between the ages of 20 and 34. Although germ-line testicular tumors respond favorably to current standard of care, testicular stromal cell (TSC) tumors derived from Sertoli cells or Leydig cells often fail to respond to...

Descripción completa

Detalles Bibliográficos
Autores principales: Aguilar, Robert, Johnson, Justin M., Barrett, Patrick, Tuohy, Vincent K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394616/
https://www.ncbi.nlm.nih.gov/pubmed/28428886
http://dx.doi.org/10.1186/s40425-017-0237-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394616/
https://www.ncbi.nlm.nih.gov/pubmed/28428886
http://dx.doi.org/10.1186/s40425-017-0237-2

Ejemplares similares